Screener
Pulse Biosciences, Inc. PLSE Operating Income
Discontinued — last reported Q2 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 16,976 | 12,088 | 29,566 | 22,401 |
| Selling, general and administrative | 8,457 | 8,187 | 15,048 | 15,918 |
| Total cost and expenses | 25,706 | 20,275 | 45,257 | 38,319 |
| Loss from operations | (25,272) | (20,275) | (44,422) | (38,319) |
| Other income (expense): | ||||
| Interest income | 600 | 1,129 | 1,193 | 2,384 |
| Other income (expense) | 15 | (22) | (9) | (28) |
| Total other income | 615 | 1,107 | 1,184 | 2,356 |
Document
FAQ
- What is Pulse Biosciences, Inc.'s operating income?
- Pulse Biosciences, Inc. (PLSE) reported operating income of -$25.27M in Q2 2026.
- How has Pulse Biosciences, Inc.'s operating income changed year-over-year?
- Pulse Biosciences, Inc.'s operating income decreased by 24.6% year-over-year, from -$20.28M to -$25.27M.
- What is the long-term trend for Pulse Biosciences, Inc.'s operating income?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating income has grown at a 5.1% compound annual growth rate (CAGR), from -$63.01M to -$76.94M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Pulse Biosciences, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude